By Jules S. Zeman
Given the recent state Supreme Court decision in Clayworth v. Pfizer Inc., California state courts are now much more attractive to antitrust plaintiffs. In fact, coupled with existing legislation, California has become a preferential forum for antitrust claims. In Clayworth, the state Supreme Court unanimously rejected the "pass-on" defense to alleged antitrust violations under the Cartwright Act, California's...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In